...
首页> 外文期刊>Biochemistry >Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein
【24h】

Identification of Coagulation Factor VIII A2 Domain Residues Forming the Binding Epitope for Low-Density Lipoprotein Receptor-Related Protein

机译:鉴定形成低密度脂蛋白受体相关蛋白结合表位的凝血因子VIII A2结构域残基

获取原文
获取原文并翻译 | 示例

摘要

Regulation of the coagulation factor VIII (fYIII) level in circulation involves a hepatic receptor low-density lipoprotein receptor-related protein (LRP).One of two major LRP binding sites in fVIII is located within the A2 domain (A2),likely exposed within the fVIII complex with von Willebrand factor and contributing to regulation of fVIII via LRP.This work aimed to identify A2 residues forming its LRP-binding site,previously shown to involve residues 484-509.Isolated A2 was subjected to alanine-scanning mutagenesis followed by expression of a set of mutants in a baculovirus system.In competition and surface plasmon resonance assays,affinities of A2 mutants K466A,R471A,R484A,S488A,R489A,R490A,H497A,and K499A for LRP were found to be decreased by 2-4-fold.This correlated with 1.3-1.5-fold decreases in the degree of LRP-mediated internalization of the mutants in cell culture.Combining these mutations into pairs led to cumulative effects,i.e.,7-13-fold decrease in affinity for LRP and 1.6-2.2-fold decrease in the degree of LRP-mediated internalization in cell culture.We conclude that the residues mentioned above play a key role in formation of the A2 binding epitope for LRP.Experiments in mice revealed an ~4.5 times shorter half-life for A2 in the circulation in comparison with that of fVIII.The half-lives of A2 mutant R471A/R484A or A2 co-injected with receptor-associated protein,a classical ligand of LRP,were prolonged by approx 1.9 and approx 3.5 times,respectively,compared to that of A2.This further confirms the importance of the mutated residues for interaction of A2 with LRP and suggests the existence of an LRP-dependent mechanism for removing A2 as a product of dissociation of activated fVIII from the circulation.
机译:循环中凝血因子VIII(fYIII)水平的调节涉及肝受体低密度脂蛋白受体相关蛋白(LRP).fVIII中两个主要LRP结合位点之一位于A2域(A2)中,可能暴露于这项工作旨在鉴定形成LRP结合位点的A2残基,以前涉及484-509位残基。分离出的A2经过丙氨酸扫描诱变突变体在杆状病毒系统中的表达。在竞争和表面等离子体共振分析中,发现A2突变体K466A,R471A,R484A,S488A,R489A,R490A,H497A和K499A对LRP的亲和力降低了2-4与细胞培养中LRP介导的突变体内部化程度降低1.3-1.5倍相关。将这些突变组合成对会导致累积效应,即对LRP和LRP的亲和力降低71-3倍1.6细胞培养中LRP介导的内在化程度降低-2.2倍。我们得出结论,上述残基在LRP的A2结合表位形成中起关键作用。小鼠实验显示半衰期缩短了约4.5倍与fVIII相比,A2突变体R471A / R484A或A2与受体相关蛋白(LRP的经典配体)共同注射的半衰期分别延长了约1.9倍和约3.5倍,这进一步证实了突变残基对于A2与LRP相互作用的重要性,并表明存在依赖LRP的机制来从循环中除去活化的fVIII解离产物A2。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号